- Home
- Companies
- usa arizona
- brain networks
Show results for
Refine by
Brain Networks Suppliers Serving Usa Arizona
4 companies found
based inHaymarket, AUSTRALIA
We build digital brain maps. Imagine trying to navigate the world without a map. You might struggle to find the right way, take a few wrong turns, bump into something unexpected, or remain lost forever. You might get to your destination, but it ...
Quicktome is neurosurgery powered by Omniscient. Designed by neurosurgeons, Quicktome backs each incision with detailed knowledge of the brain’s networks - built specific to each ...
based inKenmore, NEW YORK (USA)
Firefly Neuroscience specializes in Brain Network Analytics (BNA™), an FDA-cleared platform that uses AI and machine learning to analyze EEG data from rest and task states. It benchmarks results against a normative database of age-matched ...
Firefly Neuroscience's Brain Network Analytics (BNA™) offers an innovative approach to neurological diagnostics and treatment. Utilizing a vast proprietary database of more than 77,000 EEG scans across twelve ...
based inJerusalem, ISRAEL
BrainQ Technologies developing breakthrough precision neurology therapies using Brain Computer Interface technology. BrainQ’s goal is to develop therapies that target damaged neuronal networks and facilitate neurorecovery. We are developing a ...
BrainQ’s device uses non-invasive, frequency-tuned extremely low frequency and low intensity electromagnetic fields (ELF-EMF) with aim of promoting neurological recovery in the central nervous system (CNS). The artificial intelligence ...
based inHerzliya, ISRAEL
elminda was founded in 2006 with the goal of addressing the unmet needs of people suffering from brain related disorders. Our mission: perfect a technology that would reveal an individual’s unique brain function “signatures” or “fingerprints,” ...
CNS drugs exhibit the lowest approval success rates due to multiple challenges such as lack of efficacy in early and advanced stages of development, Poor target selection / engagement, poor translation from pre-clinical models and disease ...